首页 | 本学科首页   官方微博 | 高级检索  
     

长春瑞滨加顺铂方案治疗晚期非小细胞肺癌25例分析
引用本文:汪济东,章银秀,许扬,周平. 长春瑞滨加顺铂方案治疗晚期非小细胞肺癌25例分析[J]. 蚌埠医学院学报, 2004, 29(1): 38-39
作者姓名:汪济东  章银秀  许扬  周平
作者单位:中国人民解放军海军安庆医院, 安徽安庆 246003
摘    要:目的: 观察长春瑞滨(NVB)加顺铂(DDP)方案(NP方案)治疗晚期非小细胞肺癌(NSCLC)的疗效及不良反应。方法: 25例晚期NSCLC接受NP方案治疗,3~4周为一周期,2周期后评价疗效。结果: 原发灶CR1例,PR4例;转移灶CR1例,PR5例,总有效率为44%,中位缓解期3.7个月,中位生存期9.8个月。毒性反应主要是白细胞减少(96%),其次是静脉炎(44%)。结论: NP方案治疗晚期NSCLC有效率较高,毒性反应可耐受。

关 键 词:  非小细胞肺   长春瑞滨   顺铂   药物疗法
文章编号:1000-2200(2004)01-0038-02
收稿时间:2003-04-30
修稿时间:2003-04-30

Vinorelbine plus cisplatin therapy for treatment of advanced non-small cell lung cancer
WANG Ji dong,ZHANG Yin xiu,XU Yang,ZHOU Ping. Vinorelbine plus cisplatin therapy for treatment of advanced non-small cell lung cancer[J]. Journal of Bengbu Medical College, 2004, 29(1): 38-39
Authors:WANG Ji dong  ZHANG Yin xiu  XU Yang  ZHOU Ping
Affiliation:Department of Oncology, Anqing Hospital of PLA-Navy, Anhui 246003, China
Abstract:Objective: To evaluate the efficacy and toxicity of home made vinorelbine plus cisplatin therapy in the treatment of advanced non-small cell lung cancer(NSCLC).Methods: Twenty-five cases of stage Ⅲb to Ⅳ NSCLC received vinorelbine and cisplatin therapy.One course of treatment consisted of 3 to 4 weeks and the clinical effects were assessed after two courses of treatment.Results: The overall response rate was 44%.The medium response time was 3.7 months,and the medium survival time 9.8 months.The most frequent toxic reactions were leukopenia(96%) and phlebitis(44%).Conclusions: Vinorellbine plus cisplatin chemotherapy has a good curative effect and low toxicity in treatment of advanced NSCLC.
Keywords:cancer  non small cell lung  vinorelbine  cisplatin  chemotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《蚌埠医学院学报》浏览原始摘要信息
点击此处可从《蚌埠医学院学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号